Showing results (3411-3420 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|December 11, 2013
Optical imaging of head and neck squamous cell carcinoma in vivo using arginine-glycine-aspartic acid peptide conjugated near-infrared quantum dotsHao Huang, Yun-Long Bai, Kai Yang, et al.
Oncotargets and Therapy|October 8, 2016
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animalsMichelle Alvares Sarcinelli, Marta de Souza Albernaz, Marzena Szwed, et al.
Oncotargets and Therapy|November 2, 2016
Intravoxel incoherent motion model-based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinomaPetra Mürtz, Arndt-Hendrik Penner, Anne-Kristina Pfeiffer, et al.
Oncotargets and Therapy|June 25, 2026
MFAP2 Promotes Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]
Oncotargets and Therapy|June 25, 2026
MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression [Retraction]
Oncotargets and Therapy|June 26, 2026
NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma [Retraction]
Oncotargets and Therapy|August 20, 2026
A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case ReportNicolas Gauthier, Pierre Reimbold, Clotilde Bravetti, et al.
Oncotargets and Therapy|August 18, 2026
Autopsy-Confirmed Giant Pleural Hematoma Due to Spontaneous Hemothorax in ALK-Rearranged and TP53-Mutant Lung Adenocarcinoma: A Case ReportKeigo Kishino, Makiko Yomota, Hideo Arai, et al.
Oncotargets and Therapy|August 26, 2026
Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From TurkeyRumeysa Colak, Caner Kapar, Seher Yildiz Tacar, et al.
Oncotargets and Therapy|August 31, 2026
Tumor Genomic Profiles Associated with Clinical Benefit from Immune Checkpoint Inhibitor Therapy - An Exploratory Analysis of the INFINITY Precision Oncology RegistryKarin Potthoff, Corinne Vannier, Uwe M Martens, et al.
Pageof 674